Monthly Archives: November 2020

Abstract Importance: Coronavirus disease 2019 (COVID-19) may lead to serious illness as a result of an excessive immune response. Fluvoxamine may prevent clinical deterioration by stimulating the σ-1 receptor, which regulates cytokine production. Objective: To determine whether fluvoxamine, given during … Continue reading

Posted in Uncategorized | Comments Off on Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19

Summary: “An aspirin to make CSCs go away: Cancer stem cells (CSCs) are tumor cells with stem cell-like qualities that promote tumor progression, adaption to stress, and resistance to chemotherapy. Bhattacharya et al. found that aspirin targets CSCs in a … Continue reading

Posted in Uncategorized | Comments Off on Aspirin enhances efficacy of chemotherapy via suppression of drug efflux pump ABCG2

https://www.nature.com/articles/d41586-020-02957-3

Posted in Uncategorized | Comments Off on Neanderthal DNA highlights complexity of COVID risk factors